{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:39:32Z","timestamp":1790789972984,"version":"4.1.0"},"reference-count":167,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pathol.2019.09.012","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T01:20:52Z","timestamp":1574904052000},"page":"78-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Approach to nodal-based T-cell lymphomas"],"prefix":"10.1016","volume":"52","author":[{"given":"Laurence","family":"de Leval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2019.09.012_bib1","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib2","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1200\/JCO.2016.71.2083","article-title":"Impact of expert pathologic review of lymphoma diagnosis: study of patients from the French Lymphopath Network","volume":"35","author":"Laurent","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib3","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib4","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2017"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2019.09.012_bib5","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2012.181","article-title":"Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls","volume":"26","author":"Jaffe","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1053\/j.seminhematol.2013.11.003","article-title":"Pathology of peripheral T-cell lymphomas: where do we stand?","volume":"51","author":"Gaulard","year":"2014","journal-title":"Semin Hematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.path.2015.11.002","article-title":"T-cell lymphomas: updates in biology and diagnosis","volume":"9","author":"Ondrejka","year":"2016","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.pathol.2019.09.012_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/PAS.0000000000000188","article-title":"Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T\/NK-cell lymphomas. A North American PTCL Study Group project","volume":"38","author":"Hsi","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib9","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.3324\/haematol.2015.126300","article-title":"Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets","volume":"100","author":"de Leval","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.012_bib10","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1182\/blood-2006-10-055145","article-title":"The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells","volume":"109","author":"de Leval","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib11","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","article-title":"Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the International Peripheral T-cell Lymphoma Project","volume":"31","author":"Federico","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2141.2009.08003.x","article-title":"Advances in the understanding and management of angioimmunoblastic T-cell lymphoma","volume":"148","author":"de Leval","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/PAS.0b013e31802d68e9","article-title":"Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression","volume":"31","author":"Attygalle","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward \u2013 report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00000478-199806000-00001","article-title":"Angioimmunoblastic lymphoma (AILD-type T-cell lymphoma) with hyperplastic germinal centers","volume":"22","author":"Ree","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib17","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/modpathol.2009.12","article-title":"Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers","volume":"22","author":"Rodriguez-Justo","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1365-2559.2011.04097.x","article-title":"Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres (pattern 1) shows superior survival to patterns 2 and 3: a meta-analysis of 56 cases","volume":"60","author":"Tan","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib19","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2014-07-584953","article-title":"Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels","volume":"124","author":"Bossard","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAS.0000000000000571","article-title":"CD30 expression by B and T cells: a frequent finding in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma-not otherwise specified","volume":"40","author":"Onaindia","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2559.2011.04022.x","article-title":"c-Maf expression in angioimmunoblastic T-cell lymphoma reflects follicular helper T-cell derivation rather than oncogenesis","volume":"60","author":"Bisig","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.semdp.2011.03.003","article-title":"Follicular helper T cells: implications in neoplastic hematopathology","volume":"28","author":"Gaulard","year":"2011","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist","volume":"37","author":"Nicolae","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU","article-title":"Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified","volume":"117","author":"Zettl","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2007.06725.x","article-title":"Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases","volume":"138","author":"Willenbrock","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib27","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2019.09.012_bib29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CCO.0000000000000474","article-title":"New insights in the pathogenesis of T-cell lymphomas","volume":"30","author":"Lemonnier","year":"2018","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib30","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2019.09.012_bib31","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/leu.2015.357","article-title":"Recurrent activating mutations of CD28 in peripheral T-cell lymphomas","volume":"30","author":"Rohr","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.012_bib32","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1182\/blood-2016-02-698977","article-title":"Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas","volume":"128","author":"Vallois","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib33","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1172\/JCI92026","article-title":"Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis","volume":"127","author":"Zang","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2019.09.012_bib34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2017-11-818617","article-title":"RhoA G17V is sufficient to induce autoimmunity and promotes T cell lymphomagenesis in mice","volume":"132","author":"Ng","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ccell.2018.01.001","article-title":"RHOA G17V induces T follicular helper cell specification and promotes lymphomagenesis","volume":"33","author":"Cortes","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pathol.2019.09.012_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000555","article-title":"Angioimmunoblastic T-cell lymphomas with the RHOA p.Gly17Val mutation have classic clinical and pathologic features","volume":"40","author":"Ondrejka","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib37","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/PAS.0000000000000651","article-title":"Clinicopathologic analysis of angioimmunoblastic T-cell lymphoma with or without RHOA G17V mutation using formalin-fixed paraffin-embedded sections","volume":"40","author":"Nagao","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib38","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib39","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1073\/pnas.1617929114","article-title":"The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development","volume":"113","author":"Lemonnier","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.012_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jmoldx.2018.05.012","article-title":"Multiple ways to detect IDH2 mutations in angioimmunoblastic T-cell lymphoma from immunohistochemistry to next-generation sequencing","volume":"20","author":"Dupuy","year":"2018","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.pathol.2019.09.012_bib41","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib42","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2(R172) mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib43","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1182\/blood-2018-09-872549","article-title":"Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma","volume":"133","author":"Heavican","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib44","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2017.186767","article-title":"RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells","volume":"103","author":"Vallois","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.012_bib45","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","year":"2008"},{"key":"10.1016\/j.pathol.2019.09.012_bib46","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.humpath.2012.05.002","article-title":"Follicular T-cell lymphoma: a member of an emerging family of follicular helper T-cell derived T-cell lymphomas","volume":"43","author":"Hu","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib47","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.3324\/haematol.2016.158428","article-title":"Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin","volume":"102","author":"Dobay","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.012_bib48","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0b013e3181971591","article-title":"Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas","volume":"33","author":"Huang","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib49","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1309\/AJCPBPNV86VZENGV","article-title":"Clinicopathologic analysis of peripheral T-cell lymphoma, follicular variant, and comparison with angioimmunoblastic T-cell lymphoma: Bcl-6 expression might affect progression between these disorders","volume":"137","author":"Miyoshi","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000478-200103000-00015","article-title":"Peripheral T-cell lymphoma with follicular involvement and a CD4+\/bcl-6+ phenotype","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00428-005-0123-z","article-title":"Peripheral T-cell lymphoma with involvement of the expanded mantle zone","volume":"449","author":"Ikonomou","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2019.09.012_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41379-018-0108-5","article-title":"CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma","volume":"32","author":"Hartmann","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib53","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/modpathol.2016.113","article-title":"Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-\/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic","volume":"29","author":"Alikhan","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib54","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.leu.2404045","article-title":"Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma","volume":"20","author":"Streubel","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.012_bib55","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0b013e3182991415","article-title":"ITK\/SYK translocation in angioimmunoblastic T-cell lymphoma","volume":"37","author":"Attygalle","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib56","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2559.2007.02632.x","article-title":"Distinguishing angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified, using morphology, immunophenotype and molecular genetics","volume":"50","author":"Attygalle","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00000478-200001000-00014","article-title":"Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma?","volume":"24","author":"Rudiger","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib58","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2559.2011.03981.x","article-title":"Peripheral T cell lymphomas with follicular T helper phenotype: a new basket or a distinct entity? Revising Karl Lennert's personal archive","volume":"59","author":"Agostinelli","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib59","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00018-004-4275-9","article-title":"The emerging normal and disease-related roles of anaplastic lymphoma kinase","volume":"61","author":"Pulford","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pathol.2019.09.012_bib60","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2008.20.9759","article-title":"Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms","volume":"28","author":"Piva","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood-2016-05-717793","article-title":"Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target","volume":"129","author":"Werner","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib62","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2014-10-567461","article-title":"The biology and management of systemic anaplastic large cell lymphoma","volume":"126","author":"Hapgood","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib63","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V91.6.2076","article-title":"ALK-positive lymphoma: a single disease with a broad spectrum of morphology","volume":"91","author":"Benharroch","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib64","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study","volume":"29","author":"Lamant","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib65","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bjh.12777","article-title":"Paediatric anaplastic large cell lymphoma with leukaemic presentation in children: a report of nine French cases","volume":"165","author":"Spiegel","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib66","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199309000-00001","article-title":"A\u00a0small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma","volume":"17","author":"Kinney","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib67","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pas.0000179123.66748.c2","article-title":"ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases","volume":"30","author":"Vassallo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib68","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK-negative anaplastic large-cell lymphoma (ALCL) is clinically and immunophenotypically different from both ALK-positive ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib69","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2012.42.2345","article-title":"Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte trials","volume":"30","author":"Sibon","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib70","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parilla Castellar","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib71","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1182\/blood-2016-12-755496","article-title":"DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study","volume":"130","author":"Pedersen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib72","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/bjh.15860","article-title":"Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma","volume":"186","author":"Hapgood","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib73","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/modpathol.2010.4","article-title":"PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus","volume":"23","author":"Feldman","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib74","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/leu.2008.320","article-title":"Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas","volume":"23","author":"Feldman","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.012_bib75","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood-2018-03-838524","article-title":"Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements","volume":"132","author":"Luchtel","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib76","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1182\/blood.2019000626","article-title":"Recurrent MSC (E116K) mutations in ALK-negative anaplastic large cell lymphoma","volume":"133","author":"Luchtel","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib77","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2012-03-419937","article-title":"Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas","volume":"120","author":"Vasmatzis","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib78","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.critrevonc.2010.07.007","article-title":"Peripheral T-cell lymphoma-not otherwise specified","volume":"79","author":"Savage","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib80","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A\u00a0revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib81","series-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"227","article-title":"Peripheral T-cell lymphoma, unspecified","author":"Ralfkiaer","year":"2001"},{"key":"10.1016\/j.pathol.2019.09.012_bib82","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.40.9.995","article-title":"Histopathology and immunohistochemistry of peripheral T-cell lymphomas: a proposal for their classification","volume":"40","author":"Suchi","year":"1987","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.1994.tb08308.x","article-title":"Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group","volume":"87","author":"Siegert","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib84","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ajcp\/114.3.438","article-title":"Recurrences in nodal T-cell lymphoma. Changes in histologic appearance and immunophenotype over the course of disease","volume":"114","author":"Jones","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib85","first-page":"617","article-title":"Expression of the alpha\/beta and gamma\/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma\/delta T-cell lymphomas","volume":"137","author":"Gaulard","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib86","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2004-03-1037","article-title":"Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling","volume":"104","author":"Bonzheim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib87","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score","volume":"24","author":"Went","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib88","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jcp.42.4.398","article-title":"Aberrant phenotypes in peripheral T cell lymphomas","volume":"42","author":"Hastrup","year":"1989","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib89","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00428-004-1077-2","article-title":"Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells","volume":"445","author":"Geissinger","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2019.09.012_bib90","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/modpathol.3880265","article-title":"Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall","volume":"14","author":"Yao","year":"2001","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib91","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/PAS.0b013e31817d7452","article-title":"CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature","volume":"32","author":"Rahemtullah","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib92","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/cyto.b.20442","article-title":"Novel CD19 expression in a peripheral T cell lymphoma: a flow cytometry case report with morphologic correlation","volume":"76","author":"Rizzo","year":"2009","journal-title":"Cytom B Clin Cytom"},{"key":"10.1016\/j.pathol.2019.09.012_bib93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1309\/72CM-KAXF-66DE-4XVA","article-title":"Peripheral T-cell lymphoma complicated by a proliferation of large B cells","volume":"114","author":"Higgins","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib94","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/PAS.0b013e3180339f18","article-title":"Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features","volume":"31","author":"Balague","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib95","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PAS.0000000000000813","article-title":"Clinicopathological study of 30 cases of peripheral T-cell lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan","volume":"41","author":"Eladl","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib96","first-page":"735","article-title":"Peripheral T-cell lymphoma with t(6;14)(p25;q11.2) translocation presenting with massive splenomegaly","volume":"464","author":"Somja","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2019.09.012_bib97","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00000478-198805000-00002","article-title":"Histological and immunohistological findings in lymphoepithelioid cell lymphoma (Lennert's lymphoma)","volume":"12","author":"Patsouris","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib98","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/00000478-200012000-00006","article-title":"Lennert's lymphoma: a variant of cytotoxic T-cell lymphoma?","volume":"24","author":"Yamashita","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib99","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2012.04199.x","article-title":"Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases","volume":"61","author":"Kato","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.beha.2013.04.002","article-title":"Epstein-Barr virus-associated natural killer\/T-cell lymphomas","volume":"26","author":"Asano","year":"2013","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib101","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2015.03.002","article-title":"Epstein-Barr virus-positive nodal T\/NK-cell lymphoma: an analysis of 15 cases with distinct clinicopathological features","volume":"46","author":"Jeon","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib102","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/PAS.0000000000000323","article-title":"T-cell receptor (TCR) phenotype of nodal Epstein-Barr virus (EBV)-positive cytotoxic T-cell lymphoma (CTL): a clinicopathologic study of 39 cases","volume":"39","author":"Kato","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib103","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3324\/haematol.2017.180430","article-title":"Epstein-Barr virus-associated primary nodal T\/NK-cell lymphoma shows a distinct molecular signature and copy number changes","volume":"103","author":"Ng","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.012_bib104","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1182\/blood-2006-04-017632","article-title":"Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: a Groupe d'Etude des Lymphomes de l'Adulte (GELA) study","volume":"108","author":"Dupuis","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib105","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.084913","article-title":"CD30 expression in peripheral T-cell lymphomas","volume":"98","author":"Sabattini","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.012_bib106","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib107","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.pas.0000173238.17331.6b","article-title":"Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified","volume":"29","author":"Asano","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib108","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/cas.13652","article-title":"Reappraisal of nodal Epstein-Barr virus-negative cytotoxic T-cell lymphoma: identification of indolent CD5(+) diseases","volume":"109","author":"Yamashita","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pathol.2019.09.012_bib109","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1182\/blood-2013-11-536359","article-title":"Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma","volume":"123","author":"Iqbal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib110","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood.V96.2.685.014k26_685_690","article-title":"Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma","volume":"96","author":"Jones","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/hupa.2002.32215","article-title":"CD69 expression correlates with expression of other markers of Th1 T cell differentiation in peripheral T cell lymphomas","volume":"33","author":"Dorfman","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib112","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1309\/RF4PVCEGGN2XAF86","article-title":"CXCR4\/CD184 immunoreactivity in T-cell non-Hodgkin lymphomas with an overall Th1- Th2+ immunophenotype","volume":"119","author":"Weng","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib113","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-05-1352","article-title":"Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL","volume":"103","author":"Tsuchiya","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib114","first-page":"605","article-title":"Classification of distinct subtypes of peripheral T-cell lymphoma unspecified, identified by chemokine and chemokine receptor expression: analysis of prognosis","volume":"25","author":"Ohshima","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib115","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2013-12-544809","article-title":"GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib116","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/his.12885","article-title":"FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides","volume":"68","author":"Satou","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib117","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1182\/blood-2002-10-3297","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.hoc.2016.11.010","article-title":"T-cell prolymphocytic leukemia","volume":"31","author":"Sud","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.pathol.2019.09.012_bib119","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11899-018-0458-6","article-title":"Adult T cell leukemia-lymphoma (ATL): state of the art","volume":"13","author":"Phillips","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.pathol.2019.09.012_bib121","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.pas.0000213325.79368.2c","article-title":"Adult T-cell lymphoma\/leukemia with angioimmunoblastic T-cell lymphomalike features: report of 11 cases","volume":"31","author":"Karube","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib122","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2019.09.012_bib123","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/his.12251","article-title":"Peripheral T- and NK-cell lymphomas and their mimics: taking a step forward - report on the Lymphoma Workshop of the XVI meeting of the European Association for Haematopathology in Lisbon 2012","volume":"64","author":"Attygalle","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib125","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.pathol.2019.09.012_bib126","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib127","doi-asserted-by":"crossref","first-page":"V108","DOI":"10.1093\/annonc\/mdv201","article-title":"Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"d'Amore","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib128","first-page":"177","article-title":"Peripheral T-cell and NK-cell neoplasms: an integrated approach to diagnosis","volume":"12","author":"Chan","year":"1999","journal-title":"Mod Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2019.09.012_bib129","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/modpathol.2012.176","article-title":"Benign lymphadenopathies","volume":"26","author":"Weiss","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.semdp.2017.05.002","article-title":"A\u00a0pattern-based approach to reactive lymphadenopathies","volume":"35","author":"Tzankov","year":"2018","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib131","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00000478-199506000-00008","article-title":"Dilantin-associated lymphadenopathy. Spectrum of histopathologic patterns","volume":"19","author":"Abbondanzo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib132","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","article-title":"Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients","volume":"88","author":"Ben m'rad","year":"2009","journal-title":"Medicine"},{"key":"10.1016\/j.pathol.2019.09.012_bib133","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.3390\/pathogens7010028","article-title":"EBV-positive lymphoproliferations of B- T- and NK-cell derivation in non-immunocompromised hosts","volume":"7","author":"Dojcinov","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.pathol.2019.09.012_bib134","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)65742-2","article-title":"Pathological findings in human autoimmune lymphoproliferative syndrome","volume":"153","author":"Lim","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib135","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10875-018-0523-x","article-title":"The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions","volume":"38","author":"Rieux-Laucat","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.pathol.2019.09.012_bib136","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00125480-200307000-00003","article-title":"Kikuchi-Fujimoto lymphadenitis","volume":"10","author":"Onciu","year":"2003","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib137","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1309\/YF081L4TKYWVYVPQ","article-title":"Enigmatic Kikuchi-Fujimoto disease: a comprehensive review","volume":"122","author":"Bosch","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib138","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0002-9440(10)61767-1","article-title":"Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy","volume":"159","author":"Pileri","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib139","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/his.13858","article-title":"Florid T follicular helper cell hyperplasia associated with extranodal marginal zone lymphoma: a diagnostic pitfall which may mimic T cell lymphoma","volume":"75","author":"Vroobel","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2019.09.012_bib140","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.5858\/arpa.2014-0295-CC","article-title":"Anaplastic large cell lymphoma: features presenting diagnostic challenges","volume":"138","author":"Pletneva","year":"2014","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2019.09.012_bib141","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib142","doi-asserted-by":"crossref","first-page":"e789","DOI":"10.1200\/JCO.2011.36.9280","article-title":"Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20","volume":"29","author":"Song","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib143","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/PAS.0b013e3182487158","article-title":"Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"36","author":"Eberle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib144","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5858\/arpa.2016-0352-RS","article-title":"Nodal involvement by CD30(+) cutaneous lymphoproliferative disorders and its challenging differentiation from classical Hodgkin lymphoma","volume":"142","author":"Lezama","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2019.09.012_bib145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000000985","article-title":"Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma","volume":"42","author":"Ferrufino-Schmidt","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib146","first-page":"798","article-title":"Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma","volume":"6","author":"Zhang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib147","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1200\/JCO.2012.46.7910","article-title":"Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary","volume":"31","author":"Nguyen","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib148","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2017-12-819987","article-title":"An anaplastic T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"131","author":"Wang","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib149","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2012-06-439455","article-title":"Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival","volume":"121","author":"Venkataraman","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib150","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.humpath.2018.10.003","article-title":"The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell\/B-cell antigen expression","volume":"84","author":"Liang","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib151","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2141.2000.02045.x","article-title":"Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas","volume":"109","author":"Haralambieva","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.pathol.2019.09.012_bib152","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":"A\u00a0new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib153","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000000753","article-title":"ALK-positive large B-cell lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature","volume":"41","author":"Pan","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib154","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2003-03-0786","article-title":"ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases","volume":"102","author":"Gascoyne","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib155","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2003-04-1095","article-title":"ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases","volume":"102","author":"Onciu","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib156","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pathol.2019.09.012_bib157","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2019.09.012_bib158","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3324\/haematol.2018.197152","article-title":"CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies","volume":"104","author":"Prieto-Torres","year":"2019","journal-title":"Haematologica"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2019.09.012_bib159","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hon.2582","article-title":"Breast implant-associated anaplastic large cell lymphoma and other rare T-cell lymphomas","volume":"37","author":"de Leval","year":"2019","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.pathol.2019.09.012_bib160","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib161","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.pathol.2019.09.012_bib162","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1182\/blood-2012-01-405555","article-title":"Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma","volume":"120","author":"Agnelli","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.pathol.2019.09.012_bib163","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3324\/haematol.2012.081935","article-title":"CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features","volume":"98","author":"Bisig","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.pathol.2019.09.012_bib164","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1073\/pnas.1608839114","article-title":"Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas","volume":"114","author":"Abate","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.pathol.2019.09.012_bib165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/asheducation-2011.1.336","article-title":"Tricky and terrible T-cell tumors: these are thrilling times for testing: molecular pathology of peripheral T-cell lymphomas","volume":"2011","author":"de Leval","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.pathol.2019.09.012_bib166","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/leu.2016.331","article-title":"Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex","volume":"31","author":"Palacios","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.pathol.2019.09.012_bib167","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.3324\/haematol.2018.215103","article-title":"Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib","volume":"104","author":"Graetz","year":"2019","journal-title":"Haematologica"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302519304234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:26:30Z","timestamp":1758471990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302519304234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":167,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031302519304234"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.012","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to nodal-based T-cell lymphomas","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2019.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}